메뉴 건너뛰기




Volumn 129, Issue 4, 1998, Pages 323-326

Treating histologically mild chronic hepatitis C: Monotherapy, combination therapy, or tincture of time?

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERLEUKIN 10; NONSTEROID ANTIINFLAMMATORY AGENT; RIBAVIRIN; THYMOSIN ALPHA1;

EID: 0031852042     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-4-199808150-00010     Document Type: Review
Times cited : (16)

References (26)
  • 1
    • 0028998145 scopus 로고
    • Clinical outcomes after transfusion-associated hepatitis C
    • Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 1995;332:1463-6
    • (1995) N Engl J Med. , vol.332 , pp. 1463-1466
    • Tong, M.J.1    El-Farra, N.S.2    Reikes, A.R.3    Co, R.L.4
  • 2
    • 15644380122 scopus 로고    scopus 로고
    • Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-α therapy
    • Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C, et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-α therapy. Ann Intern Med. 1997;127:875-81.
    • (1997) Ann Intern Med. , vol.127 , pp. 875-881
    • Marcellin, P.1    Boyer, N.2    Gervais, A.3    Martinot, M.4    Pouteau, M.5    Castelnau, C.6
  • 3
    • 84984533465 scopus 로고    scopus 로고
    • Long-term efficacy of ribavirin plus interferon α in the treatment of chronic hepatitis C
    • Lai MY, Kao JH, Yang PM, Wang JT, Chen PJ, Chan KW, et al. Long-term efficacy of ribavirin plus interferon α in the treatment of chronic hepatitis C. Gastroenterology. 1996;11:1307-12.
    • (1996) Gastroenterology , vol.11 , pp. 1307-1312
    • Lai, M.Y.1    Kao, J.H.2    Yang, P.M.3    Wang, J.T.4    Chen, P.J.5    Chan, K.W.6
  • 4
    • 0032501714 scopus 로고    scopus 로고
    • Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group
    • Reichard O, Norkrans G, Fryden A, Braconier JH, Sonnerbörg A, Weiland O. Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group. Lancet. 1998;351:83-7.
    • (1998) Lancet , vol.351 , pp. 83-87
    • Reichard, O.1    Norkrans, G.2    Fryden, A.3    Braconier, J.H.4    Sonnerbörg, A.5    Weiland, O.6
  • 5
    • 0009528429 scopus 로고    scopus 로고
    • Retreatment of relapse after interferon therapy for chronic hepatitis C: An international randomized controlled trial of interferon plus ribavirin vs interferon alone
    • Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon S, Trepo C, et al. Retreatment of relapse after interferon therapy for chronic hepatitis C: an international randomized controlled trial of interferon plus ribavirin vs interferon alone [Abstract], Hepatology. 1997;26:249A.
    • (1997) Hepatology , vol.26
    • Davis, G.L.1    Esteban-Mur, R.2    Rustgi, V.3    Hoefs, J.4    Gordon, S.5    Trepo, C.6
  • 7
    • 0030886964 scopus 로고    scopus 로고
    • National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C
    • National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology. 1997;26(Suppl 1):2S-10S.
    • (1997) Hepatology , vol.26 , Issue.1 SUPPL.
  • 9
    • 0030720484 scopus 로고    scopus 로고
    • Estimates of the cost-effectiveness of a single course of interferon-α2b in patients with histologically mild chronic hepatitis C
    • Bennett WG, Inoue Y, Beck JR, Wong JB, Pauker SG, Davis GL. Estimates of the cost-effectiveness of a single course of interferon-α2b in patients with histologically mild chronic hepatitis C. Ann Intern Med. 1997;127: 855-65.
    • (1997) Ann Intern Med. , vol.127 , pp. 855-865
    • Bennett, W.G.1    Inoue, Y.2    Beck, J.R.3    Wong, J.B.4    Pauker, S.G.5    Davis, G.L.6
  • 10
    • 0031573119 scopus 로고    scopus 로고
    • Interferon-α for chronic hepatitis C: Reducing the uncertainties
    • Koff RS. Interferon-α for chronic hepatitis C: reducing the uncertainties [Editorial]. Ann Intern Med. 1997;127:918-20.
    • (1997) Ann Intern Med. , vol.127 , pp. 918-920
    • Koff, R.S.1
  • 11
    • 0014748535 scopus 로고
    • Asymptomatic chronic hepatitis. Correlation between isolated serum transaminase abnormality and liver biopsy
    • Levine RA, Ranek L. Asymptomatic chronic hepatitis. Correlation between isolated serum transaminase abnormality and liver biopsy. Gastroenterology. 1970;58:371-8.
    • (1970) Gastroenterology , vol.58 , pp. 371-378
    • Levine, R.A.1    Ranek, L.2
  • 12
    • 0029778988 scopus 로고    scopus 로고
    • An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group
    • Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24: 289-93.
    • (1996) Hepatology , vol.24 , pp. 289-293
    • Bedossa, P.1    Poynard, T.2
  • 13
    • 0030933395 scopus 로고    scopus 로고
    • Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups
    • Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349:825-32.
    • (1997) Lancet , vol.349 , pp. 825-832
    • Poynard, T.1    Bedossa, P.2    Opolon, P.3
  • 15
    • 0030955348 scopus 로고    scopus 로고
    • Therapy of hepatitis C: Patients with normal aminotransferase levels
    • Marcellin P, Levy S, Erlinger S. Therapy of hepatitis C: patients with normal aminotransferase levels. Hepatology. 1997;26(3 Suppl 1):133S-6S.
    • (1997) Hepatology , vol.263 , Issue.1 SUPPL.
    • Marcellin, P.1    Levy, S.2    Erlinger, S.3
  • 16
    • 0030767251 scopus 로고    scopus 로고
    • Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels
    • Silverman AL, Piquette DL, Filipiak CL, Neill JS, Bayati N, Gordan SC. Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels. Am J Gastroenterol. 1997;92:1793-5.
    • (1997) Am J Gastroenterol. , vol.92 , pp. 1793-1795
    • Silverman, A.L.1    Piquette, D.L.2    Filipiak, C.L.3    Neill, J.S.4    Bayati, N.5    Gordan, S.C.6
  • 17
    • 0031952915 scopus 로고    scopus 로고
    • Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity
    • Mathurin P, Moussalli J, Cadranel JF, Thibault V, Charlotte F, Dumouchel P, et al. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology. 1998;27:868-72.
    • (1998) Hepatology , vol.27 , pp. 868-872
    • Mathurin, P.1    Moussalli, J.2    Cadranel, J.F.3    Thibault, V.4    Charlotte, F.5    Dumouchel, P.6
  • 18
    • 0030882650 scopus 로고    scopus 로고
    • Chronic hepatitis C virus infection with repeatedly normal aminotransferase levels: Disease or not disease?
    • Pawlotsky JM. Chronic hepatitis C virus infection with repeatedly normal aminotransferase levels: disease or not disease? [Editorial] Am J Gastroenterol. 1997;92:1775-7.
    • (1997) Am J Gastroenterol. , vol.92 , pp. 1775-1777
    • Pawlotsky, J.M.1
  • 19
    • 15644383207 scopus 로고    scopus 로고
    • Efficacy of consensus interferon (CIFN) against chronic HCV patients with high viral titer. The Consensus Interferon Clinical Study Group
    • Suzuki H, Iino S, Omata M, Kumada H, Hino K. Efficacy of consensus interferon (CIFN) against chronic HCV patients with high viral titer. The Consensus Interferon Clinical Study Group [Abstract]. Hepatology. 1997; 26:422A.
    • (1997) Hepatology , vol.26
    • Suzuki, H.1    Iino, S.2    Omata, M.3    Kumada, H.4    Hino, K.5
  • 23
    • 0030912338 scopus 로고    scopus 로고
    • The molecular virology of hepatitis C
    • Major ME, Feinstone SM. The molecular virology of hepatitis C. Hepatology. 1997;25:1527-38.
    • (1997) Hepatology , vol.25 , pp. 1527-1538
    • Major, M.E.1    Feinstone, S.M.2
  • 24
    • 0030852745 scopus 로고    scopus 로고
    • Gene therapy for chronic viral hepatitis: Ribozymes, antisense oligonucleotides, and dominant negative mutants
    • von Weizsäcker F, Wieland S, Köck J, Offensperger WB, Offensperger S, Moradpour D, et al. Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants. Hepatology. 1997;26:251-5.
    • (1997) Hepatology , vol.26 , pp. 251-255
    • Von Weizsäcker, F.1    Wieland, S.2    Köck, J.3    Offensperger, W.B.4    Offensperger, S.5    Moradpour, D.6
  • 25
    • 0031802131 scopus 로고    scopus 로고
    • Targeted inhibition of hepatitis C virus-directed gene expression in human hepatoma cell lines
    • Wu CH, Wu GY. Targeted inhibition of hepatitis C virus-directed gene expression in human hepatoma cell lines. Gastroenterology. 1998;114:1304-12.
    • (1998) Gastroenterology , vol.114 , pp. 1304-1312
    • Wu, C.H.1    Wu, G.Y.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.